CytoSorbents Corp (CTSO)
0.8134
+0.01
(+1.54%)
USD |
NASDAQ |
Apr 19, 16:00
0.8272
+0.01
(+1.70%)
After-Hours: 20:00
CytoSorbents Research and Development Expense (Quarterly): 4.096M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.096M |
| September 30, 2023 | 3.749M |
| June 30, 2023 | 3.669M |
| March 31, 2023 | 4.214M |
| December 31, 2022 | 3.402M |
| September 30, 2022 | 3.290M |
| June 30, 2022 | 4.184M |
| March 31, 2022 | 4.243M |
| December 31, 2021 | 6.137M |
| September 30, 2021 | 4.262M |
| June 30, 2021 | 3.699M |
| March 31, 2021 | 2.282M |
| December 31, 2020 | 2.686M |
| September 30, 2020 | 1.754M |
| June 30, 2020 | 2.406M |
| March 31, 2020 | 1.965M |
| December 31, 2019 | 3.558M |
| September 30, 2019 | 3.185M |
| June 30, 2019 | 2.930M |
| March 31, 2019 | 2.419M |
| December 31, 2018 | 2.424M |
| September 30, 2018 | 1.943M |
| June 30, 2018 | 1.576M |
| March 31, 2018 | 1.725M |
| December 31, 2017 | 1.666M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.6432M |
| June 30, 2017 | 0.458M |
| March 31, 2017 | 0.4695M |
| December 31, 2016 | 0.9527M |
| September 30, 2016 | 1.172M |
| June 30, 2016 | 1.092M |
| March 31, 2016 | 0.8561M |
| December 31, 2015 | 1.252M |
| September 30, 2015 | 0.8663M |
| June 30, 2015 | 0.8017M |
| March 31, 2015 | 0.951M |
| December 31, 2014 | 0.9677M |
| September 30, 2014 | 0.8803M |
| June 30, 2014 | 0.347M |
| March 31, 2014 | 0.2368M |
| December 31, 2013 | 0.0324M |
| September 30, 2013 | 0.2942M |
| June 30, 2013 | 0.7082M |
| March 31, 2013 | 0.7041M |
| December 31, 2012 | 0.6781M |
| September 30, 2012 | 0.5543M |
| June 30, 2012 | 0.7157M |
| March 31, 2012 | 0.6329M |
| December 31, 2011 | 0.4947M |
| September 30, 2011 | 0.7796M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.754M
Minimum
Sep 2020
6.137M
Maximum
Dec 2021
3.459M
Average
3.558M
Median
Dec 2019
Research and Development Expense (Quarterly) Benchmarks
| Delcath Systems Inc | 4.709M |
| Star Equity Holdings Inc | -- |
| Exact Sciences Corp | 114.92M |
| Illumina Inc | 341.00M |
| Progyny Inc | -- |